Screener
Harmony Biosciences Holdings, Inc. HRMY Q2 2025 earnings
Reported August 5, 2025 · Before market open
Revenue$200.5MMiss by $19.7M
EPS$0.68Miss by $0.10
Revenue estimate$220.2M
EPS estimate$0.78
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$274.5M
EPS estimate$1.11
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harmony Biosciences Holdings, Inc. report Q2 2025 earnings?
- Harmony Biosciences Holdings, Inc. (HRMY) reported Q2 2025 earnings on August 5, 2025 before market open.
- What were Harmony Biosciences Holdings, Inc.'s Q2 2025 revenue and EPS?
- Harmony Biosciences Holdings, Inc. reported revenue of $200.5M and eps of $0.68 for Q2 2025.
- Did Harmony Biosciences Holdings, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $220.2M by $19.7M. EPS missed the consensus estimate of $0.78 by $0.10.
- How did Harmony Biosciences Holdings, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 16.0% from $172.8M a year earlier and eps grew 240.0% from $0.20.
- Where can I find Harmony Biosciences Holdings, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001558370-25-010182) and the 10-Q periodic report (0001558370-25-010185) directly on SEC EDGAR. The filing index links above go to sec.gov.
